
Journal of Medicinal Chemistry p. 170 - 173 (1989)
Update date:2022-08-10
Topics:
Kendrick
Danzin
Kolb
2,2-Difluoro-5-hexyne-1,4-diamine was prepared in an eight-step sequence from ethyl 2,2-difluoro-4-pentenoate and tested as an inhibitor of mammalian ornithine decarboxylase. It produces a time-dependent inhibition of the enzyme in vitro which shows saturation kinetics, with K(I) = 10 μM and τ( 1/2 ) = 2.4 min. In rats, it produces a rapid, long-lasting, and dose-dependent decrease of ornithine decarboxylase activity in the ventral prostate, testis, and thymus. In contrast with the nonfluorinated analogue 5-hexyne-1,4-diamine (Danzin et al. Biochem. Pharmacol. 1983, 32, 941), 2,2-difluoro-5-hexyne-1,4-diamine is not a substrate of mitochondrial monoamine oxidase.
View More
website:http://www.chinacharm.cn/
Contact:86 551 5316260
Address:No. 211,XiangZhang Road,Hefei City,Anhui Province,China
Chongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
Shanghai Demand Chemical Co., ltd,China
Contact:86-021-55237578/55239122
Address:Room 3H, No.578, Yingkou Road, Yangpu District, Shanghai, China
website:http://www.shengmaochem.com
Contact:86-27-82853423, 82819281
Address:Rm 202, A Unit Huaqiao Building No. 2, Lihuangpi Road, Wuhan, China
Contact:+86-571-86491666
Address:SHI XIANG ROAD
Doi:10.1016/j.bmcl.2006.09.051
(2007)Doi:10.1002/hlca.19370200192
(1937)Doi:10.1016/S0040-4039(03)00041-8
(2003)Doi:10.1002/cjoc.201400406
(2014)Doi:10.1016/0223-5234(96)88238-9
(1995)Doi:10.1002/jhet.3123
(2018)